Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15
Published January 17, 2024 · Recall initiated: January 2, 2024
Summary
FDA records drug Class II recall D-0223-2024, published January 17, 2024 and initiated January 2, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Completed; Reported quantity: 38,952 bottles; Lot: Lot #: T2304007, Exp 7/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email if TIZANIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TIZANIDINE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- USA Nationwide
- UPC
- 0355111180104
- Lot
- Lot #: T2304007, Exp 7/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAbuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for:January 17, 2024
- FDAEban's Bakehouse Sweet Indulgences - Variety Pack (12 pieces/cookies) packaged in 11.85oz cardboard candy boxJanuary 17, 2024
- FDATizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories LimitedJuly 26, 2023
- FDATizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottlesJuly 12, 2023
- FDATizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only,July 12, 2023
- FDATizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited,August 25, 2021
Questions about this recall
Was Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15 recalled?
Yes. FDA published recall D-0223-2024 on January 17, 2024. Reported hazard: Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TIZANIDINE. UPC: 0355111180104.